Deterministic Single Cell Encapsulation in PEG Norbornene Microgels for Promoting anti‐Inflammatory Response and Therapeutic Delivery of Mesenchymal Stromal Cells

Hangjun Si,Yuanzhuo Chen,Kun Jiang,Ke Ma,Edward Ramsey,John Oakey,Mingming Sun,Zhongliang Jiang
DOI: https://doi.org/10.1002/adhm.202304386
IF: 10
2024-02-21
Advanced Healthcare Materials
Abstract:Tissue engineering at single cell resolution has informed enhanced therapeutic efficacy. Droplet‐microfluidics offers a powerful platform that allows deterministic single cell encapsulation into aqueous droplets, yet the direct encapsulation of cells into microgels remains challenging. Here, we report the design of a microfluidic device that is capable of single cell encapsulation within PEG norbornene (PEGNB) hydrogels on‐chip. Cells are first ordered in media within a straight microchannel via inertial focusing, followed by the introduction of PEGNB solution from two separate, converging channels. Droplets are thoroughly mixed by passage through a serpentine channel, and microgels are formed by photo‐photopolymerization. This platform uniquely enables both single cell encapsulation and excellent cell viability post photo‐polymerization. More than 90% of singly encapsulated mesenchymal stromal cells (MSCs) remained alive for 7 days. Notably, singly encapsulated MSCs had elevated expression levels in genes that code anti‐inflammatory cytokines, for example, IL‐10 and TGF‐β, thus enhanced secretion of proteins of interest. Following injection into a mouse model with induced inflammation, singly encapsulated MSCs showed a strong retention rate in vivo, and reduced overall inflammation and mitigated liver damage. These translational results indicate that deterministic single cell encapsulation could find use in a broad spectrum of tissue engineering applications. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?